Economists begin by asking what would happen in a completely free market. Then we ask whether government intervention of some ...

Trump’s executive order to cap U.S. costs risks limiting the supply of new pharmaceuticals. President Donald Trump’s ...

Experts said the president's executive order could work in lowering costs, but it won't make for an immediate fix.

While Trump has not yet turned to price controls to address America‘s absurdly high drug prices, Monday‘s executive order ...

If the goals of his executive order are achieved, price reductions would not happen “almost immediately,” experts say.

Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices ...

The government held a consultative meeting with private sector stakeholders on Thursday to promote the use of AI in drug ...

President Donald Trump signed a new executive order Monday aimed at slashing the cost of prescription drugs in the United ...

At CTO West Coast, an expert discussed the implications of the FDA’s expedited approval programmes with a spotlight on ...

Kaddis said insurers are locked in a cat-and-mouse game with drugmakers as the insurance sector invests in biosimilars and ...

Experts said Trump’s action could lower the cost of prescription drugs, but they cautioned it's far from an immediate fix.

If prescription savings are to be passed on to Americans not on Medicare, Congress likely would have to pass a law to enact ...